Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab (RTX) Therapy in Steroid Resistant Patients or Patients Relapsing After Intravenous Steroids With Active TAO

NCT02378298 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT02378298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab (RTX) Therapy in Steroid Resistant Patients or Patients Relapsing After Intravenous Steroids With Active TAO
Lead sponsor
Göteborg University
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
February 1, 2020
Enrollment
38 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ophthalmopathy, thyroid-associated